Azin Kheirkhah: New Research on OSE-IgM Antibodies and Age-Related Macular Degeneration
Azin Kheirkhah, Scientist at the Medical University of Innsbruck, shared a post on LinkedIn about a recent article she and her colleagues co-authored, published in Arteriosclerosis, Thrombosis, and Vascular Biology, adding
“I’m very happy to share that our recent work has been published in Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB)
This study investigated the association between circulating IgM antibodies against oxidation-specific epitopes (OSEs) and age-related macular degeneration (AMD).
We found that higher levels of OSE-IgM were associated with a lower likelihood of late AMD, suggesting a potential protective role of these antibodies in AMD development and progression.
I’m especially happy to share this publication as it is one of the outcomes of my time in Vienna and a great collaboration between the Medical University of Innsbruck– Florian Kronenberg Lab and the Medical University of Vienna – Christoph Binder Lab.
A big thank you to all co-authors for their contributions, expertise, and collaboration throughout this project. It was a pleasure working together on this!
P.S. A big thank you to Maria Ozsvar Kozma , who helped me with all the measurements! Here’s a little behind-the-scenes look at all the plates used in this study.”
Title: Circulating IgM Antibody Levels Against Oxidation-Specific Epitopes and Their Association With Age-Related Macular Degeneration
Authors: Azin Kheirkhah, Maria Oszvar-Kozma, Claudia Lamina, Klaus J. Stark, Taras Afonyushkin, Martina E. Zimmermann, Caroline Brandl, Iris M. Heid, Florian Kronenberg, Christoph J. Binder
Stay updated on all scientific advances with Hemostasis Today.
-
Aug 10, 2026, 15:11Shazmah Shaikh: How Does a Thrombus Actually Form?
-
Aug 10, 2026, 15:01William Wallace: Is Your Cholesterol Test Missing Your Biggest Inherited Risk?
-
Aug 10, 2026, 14:52Mohammed Maher Babiker: When Anaemia and Thrombocytopenia Occur Together
-
Aug 10, 2026, 14:38Eloïse Laouenan: Closing ISTH 2026 with Two Outstanding Research Presentations
-
Aug 10, 2026, 14:30Erik Rafflenbeul: Preventing the Need for Coronary Stenting
-
Aug 10, 2026, 14:26Tabassum Rahman: Aboriginal Women’s Voices in Cardiovascular Health Research
-
Aug 10, 2026, 14:01Your Diagnosis Does Not Define Your Future – Glanzmann’s Research Foundation
-
Aug 10, 2026, 13:36Ianalumab and the Changing Landscape of ITP Treatment – ITP Support Association
-
Aug 10, 2026, 11:20Jean-Jacques Kiladjian: Interferon-Alpha in Polycythemia Vera Balancing Efficacy and Autoimmune Risk